 |
 |
|
|
RESÚMENES NOVIEMBRE 2007 |
Psychotic Disorders
& Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
5 –
doble-ciego o metanálisis; 4 – subanálisis o simple
ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión
2! - Information for Healthcare
Professionals Haloperidol
TEXTO GRATUITO
3 - Adaptive evolution of genes underlying
schizophrenia
Bernard Crespi, Kyle Summers, Steve Dorus
Proc
Royal Soc Biol Sci. Volume 274, Number 1627 /
November 22, 2007:2801-2810
3! -
Questioning an Axiom: Better Prognosis for Schizophrenia in the Developing
World?
Alex Cohen, Vikram Patel, R. Thara and Oye Gureje
Schizophrenia
Bulletin Advance Access published September 28, 2007
TEXTO GRATUITO
5 -
Galantamine for the Treatment of Cognitive
Impairments in People With Schizophrenia
Robert W. Buchanan, Robert R. Conley, Dwight Dickinson, M. Patricia Ball,
Stephanie Feldman, James M. Gold, and Robert P. McMahon
Am J Psychiatry Published
November 6, 2007
3 -
Serum prolactin levels, plasma risperidone
levels, polymorphism of cytochrome P450 2D6 and
clinical response in patients with schizophrenia
Lei Wang, Lan Yu, Ai-Ping Zhang, Chao Fang,
Jing Du, Niu-Fan Gu, Sheng-Ying Qin, Guo-Yin Feng, Xing-Wang Li, Qing-He Xing, Lin He
Journal of Psychopharmacology, Vol. 21, No. 8, 837-842
(2007)
3! -
Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune
cells in vitro
Philip HeiSer, Frank Enning,
Jürgen-Christian Krieg, Helmut Vedder
Journal of Psychopharmacology, Vol. 21, No. 8, 851-856
(2007)
3! -
Coronary artery disease risk factors in patients with schizophrenia: effects of
short term antipsychotic treatment
Asli Sarandol , Selcuk Kirli, Cengiz Akkaya,
Nihal Ocak, Esma Eroz, Emre
Sarandol
Journal of Psychopharmacology, Vol. 21, No. 8, 857-863
(2007)
3! - Initial Heritability Analyses
of Endophenotypic Measures for Schizophrenia. The
Consortium on the Genetics of Schizophrenia
Tiffany A. Greenwood, David L.
Braff, Gregory A. Light, Kristin S. Cadenhead, Monica E. Calkins, Dorcas
J. Dobie, Robert Freedman, Michael F. Green, Raquel E. Gur,
Ruben C. Gur, Jim Mintz,
Keith H. Nuechterlein, Ann Olincy,
Allen D. Radant, Larry J. Seidman,
Larry J. Siever, Jeremy M. Silverman, William S.
Stone, Neal R. Swerdlow, Debby W. Tsuang,
Ming T. Tsuang, Bruce I. Turetsky,
Nicholas J. Schork
Arch Gen Psychiatry. 2007;64(11):1242-1250
3< - A prospective 6-month
analysis of the naturalistic use of aripiprazole -
factors predicting favourable outcome
D. Taylor, J. Atkinson, C. Fischetti, A. Sparshatt, S. Jones
Acta Psychiatrica
Scandinavica 2007; 116 (6), 461–466
3 -
Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic
response to olanzapine in female schizophrenic
patients
Nada Bozina, Martina Rojnic Kuzman, Vesna Medved,
Nikolina Jovanovic, Jadranka Sertic and Ljubomir Hotujac
Journal
of Psychiatric Research. Volume 42, Issue 2, January 2008, Pages 89-97
3 - Possible Association of the
Pro-Melanin-Concentrating Hormone Gene with a Greater Body Mass Index as a Side Effect of the Antipsychotic Olanzapine
Chagnon YC, Bureau A,
Gendron D, Bouchard RH, Mérette C, Roy M-A, Maziade M
Am
J Med Genet Part B 2007;144B:1063-1069
3 -
The Effect of Long-Acting Risperidone on Working
Memory in Schizophrenia: A Functional Magnetic Resonance Imaging Study
Surguladze, Simon A; Chu, Elvina M;
Evans, Anthony; Anilkumar, Anantha
P.P; Patel, Maxine X; Timehin, Clive; David, Anthony
S
Journal of Clinical
Psychopharmacology. 27(6):560-570,
December 2007
5 - Amoxapine as an Antipsychotic: Comparative Study Versus Haloperidol
Chaudhry, Imran B; Husain, Nusrat; Khan, Salahuddin; Badshah, Sareer; Deakin, Bill; Kapur, Shitij
Journal of Clinical Psychopharmacology. 27(6):575-581, December 2007
4 - Lamotrigine as Add-On Therapy in Schizophrenia: Results of
2 Placebo-Controlled Trials
Goff, Donald C; Keefe, Richard; Citrome,
Leslie; Davy, Katherine; Krystal, John H; Large, Charles; Thompson, Thomas R; Volavka, Jan; Webster, Elizabeth L
Journal of Clinical
Psychopharmacology. 27(6):582-589,
December 2007
3! - Comparison
of Risk of Cerebrovascular Events in an Elderly VA
Population With Dementia Between Antipsychotic and Nonantipsychotic Users
Barnett, Mitchell J; Wehring,
Heidi; Perry, Paul J
Journal of Clinical
Psychopharmacology. 27(6):595-601,
December 2007
3 -
Clinical Implications of Antipsychotic-Induced Hyperprolactinemia
in Patients With Schizophrenia Spectrum or Bipolar
Spectrum Disorders: Recent Developments and Current Perspectives
Byerly, Matthew; Suppes,
Trisha; Tran, Quynh-Van; Baker, Ross A
Journal of Clinical
Psychopharmacology. 27(6):639-661,
December 2007
5< - Clozapine and Olanzapine Are
Associated With Food Craving and Binge Eating: Results From
A Randomized Double-Blind Study
Kluge, Michael; Schuld,
Andreas; Himmerich, Hubertus; Dalal,
Mira; Schacht, Alexander; Wehmeier, Peter M; Hinze-Selch, Dunja; Kraus,
Thomas; Dittmann, Ralf W; Pollmacher,
Thomas
Journal of Clinical
Psychopharmacology. 27(6):662-666,
December 2007
3 - Cost-effectiveness of antipsychotics for outpatients
with chronic schizophrenia
M. Obradovic, A. Mrhar,
M. Kos
International Journal of Clinical Practice 2007; 61
(12), 1979–1988
3 -
Risperidone in adolescent schizophrenic psychoses: A
retrospective study
Michal Hrdlicka;
Iva Dudova
International
Journal of Psychiatry in Clinical Practice, Volume 11, Issue 4 2007, pages 273
- 278
3! - Are obstetric complications related to adult
schizophrenia? A case-control study
Mario Amore, Francesco Pisani, Chiara Balista, Marco Sarchiapone, Robin
McCreadie
Acta Neuropsychiatrica
2007; 19 (6), 338–343
3 -
Neurological soft signs and their relationship to 1-year outcome in first-episode
schizophrenia
Radovan
Prikryl, Eva Ceskova, Tomas Kasparek
and Hana Kucerova
European
Psychiatry. Volume 22, Issue 8, November 2007, Pages 499-504
5 -
Vitamin B6 Treatment for Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled,
Crossover Study
Vladimir Lerner, Chanoch
Miodownik, Alexander Kaptsan,
Yuly Bersudsky, Igor Libov, Ben-Ami Sela, and Eliezer Witztum
J Clin Psychiatry 2007;68:1648-1654
3! -
A Comparison of Selected Risk Factors for Unipolar
Depressive Disorder, Bipolar Affective Disorder, Schizoaffective Disorder, and
Schizophrenia From a Danish Population-Based Cohort
Thomas Munk Laursen, Trine Munk-Olsen, Merete
Nordentoft, and Preben Bo
Mortensen
J Clin Psychiatry 2007;68:1673-1681
5! -
Blood Glucose and Schizophrenia: A Systematic Review of Prospective Randomized
Clinical Trials
Chris J. Bushe, and Brian E. Leonard
J Clin Psychiatry 2007;68:1682-1690
3! -
A 12-Week Randomized Clinical Trial to Evaluate Metabolic Changes in
Drug-Naive, First-Episode Psychosis Patients Treated With Haloperidol, Olanzapine, or Risperidone
Rocio Perez-Iglesias, Benedicto Crespo-Facorro, Jose
Antonio Amado, Maria Teresa Garcia-Unzueta, Maria Luz
Ramirez-Bonilla, Cesar Gonzalez-Blanch, Obdulia
Martinez-Garcia; and Jose Luis Vazquez-Barquero
J Clin Psychiatry 2007;68:1733-1740
1-3 -
The
Troy A. Moore, Robert W. Buchanan, Peter F.
Buckley, John A. Chiles, Robert R. Conley, M. Lynn Crismon,
Susan M. Essock, Molly Finnerty,
Stephen R. Marder, Del D. Miller, Joseph P. McEvoy, Delbert G. Robinson, Nina R. Schooler,
Steven P. Shon, T. Scott Stroup, and Alexander L.
Miller
J Clin Psychiatry 2007;68:1751-1762
5<
- Maintenance Treatment With
Risperidone or Low-Dose Haloperidol in First-Episode
Schizophrenia: 1-Year Results of a Randomized Controlled Trial Within the
German Research Network on Schizophrenia
Wolfgang Gaebel,
Mathias Riesbeck; Wolfgang Wölwer,
Ansgar Klimke, Matthias Eickhoff, Martina von Wilmsdorff,
Maria C. Jockers-Scherübl, Kai-Uwe
Kühn, Matthias Lemke, Andreas Bechdolf,
Stefan Bender, Detlef Degner,
Ralf Schlösser, Lutz G. Schmidt, Andrea Schmitt,
Markus Jäger, Gerd Buchkremer, Peter Falkai, Stefan Klingberg, Wolfgang Köpcke,
Wolfgang Maier, Heinz Häfner, Christian Ohmann, Hans J. Salize, Frank
Schneider, and Hans-Jürgen Möller,
for the German Study Group on First-Episode Schizophrenia
J Clin Psychiatry 2007;68:1763-1774
3 -
Effect of Olanzapine, Risperidone,
and Haloperidol Treatment on Weight and Body Mass Index in First-Episode
Schizophrenia Patients in
Sahoo Saddichha,
Narayana Manjunatha, Shahul Ameen, and Sayeed Akhtar
J Clin Psychiatry 2007;68:1793-1798
3 - Suicidality
in middle aged and older patients with schizophrenia and depressive symptoms:
relationship to functioning and Quality of Life
J. Kasckow, L. Montross, S. Golshan, S. Mohamed,
T. Patterson, E. Sollanzano, S. Zisook
International Journal of Geriatric Psychiatry. Volume 22, Issue 12, Pages 1223 -
1228
3 -
Phosphodiesterase inhibitors—Are
they potential neuroleptic drugs?
Axel Becker and
Gisela Grecksch
Behavioural Brain
Research.
Volume 186, Issue 2, 25 January 2008, Pages 155-160
3 -
Predictors of the evolution towards schizophrenia or mood disorder in patients
with schizophreniform disorder
Carlo Marchesi, Matteo Paini, Luca Ruju, Luca Rosi, Giuliano Turrini and
Carlo Maggini
Schizophrenia
Research.
Volume 97, Issues 1-3, December 2007, Pages 1-5
3! -
Obstetric conditions and risk of first admission with schizophrenia: A Danish
national register based study
Majella Byrne,
Esben Agerbo, Birgit Bennedsen, William W. Eaton and Preben
Bo Mortensen
Schizophrenia
Research.
Volume 97, Issues 1-3, December 2007, Pages 51-59
3 -
Trends in psychiatric hospitalisation of people with
schizophrenia: A register-based investigation over the last three decades
Barbara Lay,
Carlos Nordt and Wulf Rössler
Schizophrenia
Research.
Volume 97, Issues 1-3, December 2007, Pages 68-78
3! -
Gray matter volume differences and the effects of smoking on gray matter in
schizophrenia
Jason R. Tregellas, Shireen Shatti, Jody L. Tanabe, Laura F. Martin, Linzi Gibson, Korey Wylie and
Donald C. Rojas
Schizophrenia
Research.
Volume 97, Issues 1-3, December 2007, Pages 242-249
3 - Accuracy of body image perception and preferred weight loss
strategies in schizophrenia: a controlled pilot study
C. Loh, J. M. Meyer, S. G. Leckband
Acta Psychiatrica Scandinavica (OnlineEarly
Articles). Nov 2007
3 -
Switching to Long-Acting Injectable Risperidone is
Beneficial with Regard to Clinical Outcomes, Regardless of Previous
Conventional Medication in Patients with Schizophrenia
T. De Marinis, P. T. Saleem,
P. Glue, W. J. Arnoldussen, R. Teijeiro, A. Lex,
M. A. Latif, R. Medori
Pharmacopsychiatry 2007; 40: 257-263
3 -
Risk Factors for Medication
Non-Adherence in Patients with First Episode Schizophrenia and Related
Disorders; A Prospective Five Year Follow-Up
L. de Haan, T. van Amelsvoort, P. Dingemans,
D. Linszen
Pharmacopsychiatry 2007; 40: 264-268
3! -
Clinical and Social
Determinants of Long-Term Use of Benzodiazepines and its Impact on Quality of
Life of Chinese Schizophrenia Patients
Y.-T. Xiang,
Y.-Z. Weng, C.-M. Leung, W.-K. Tang,
G. S. Ungvari
Pharmacopsychiatry 2007; 40: 269-274
5 -
Course of Recovery of
Cognitive Impairment in Patients with Schizophrenia: A Randomised
Double-blind Study Comparing Sertindole and
Haloperidol
B. Gallhofer, P. Jaanson,
A. Mittoux, P. Tanghøj,
S. Lis, S. Krieger
Pharmacopsychiatry 2007; 40: 275-286
3! - Association between antipsychotic drugs, antidepressant
drugs and venous thromboembolism: results from the
EDITH case-control study
K. Lacut, G. Le Gal, F. Couturaud,
G. Cornily, C. Leroyer, D. Mottier, E. Oger
Fundamental & Clinical Pharmacology 2007; 21 (6),
643–650
3< - Long-term safety and efficacy of
long-acting risperidone in elderly psychotic patients
Werner Kissling,
Per Glue, Rossella Medori,
Steve Simpson
Human
Psychopharmacology: Clinical and Experimental. Published
Online: 28
Sep 2007
3< - Retrospective database analysis
on the effectiveness of typical and atypical antipsychotic drugs in an
outpatient clinic setting
Cengiz Akkaya,
Asli Sarandol, Sengul Cangur, Selcuk Kirli
Human
Psychopharmacology: Clinical and Experimental. Published
Online: 17
Sep 2007
3! - Adiposity and
Insulin Sensitivity Derived from Intravenous Glucose Tolerance Tests in
Antipsychotic-Treated Patients
Dan W Haupt, Peter A Fahnestock,
Karen A Flavin, Julie A Schweiger,
Angela Stevens, Martha J Hessler,
Justin Maeda, Michael Yingling and John
W Newcomer
Neuropsychopharmacology (2007) 32, 2561–2569
3 -
Electronic monitoring of antipsychotic medication adherence in outpatients with
schizophrenia or schizoaffective disorder: An empirical evaluation of its
reliability and predictive validity
Paul A. Nakonezny, Matthew J. Byerly and
A. John Rush
Psychiatry
Research.
Volume 157, Issues 1-3, 15 January 2008, Pages 259-263
3! -
Comorbidity with Axis I Anxiety Disorders in Remitted
Psychotic Patients 1 Year After Hospitalization
Antonio Ciapparelli, Rosemma Paggini, Donatella Marazziti, Claudia
Carmassi, Maria Bianchi, Claudia Taponecco, Giorgio Consoli, Valentina
Lombardi, Gabriele Massimetti, and Liliana Dell’Osso
CNS Spectr.
2007;12(12):913-919
TEXTO
GRATUITO
3 -
Complementary Therapies for Schizophrenia: Expanding the Clinician's Toolbox
Psych Times. September 09,
2007
TEXTO
GRATUITO
3 - Weight
gain, dyslipidemia and altered parameters for
metabolic syndrome on first episode psychotic patients after six-month follow-
up
ATTUX, Cecília,
QUINTANA, Maria Inês and CHAVES, Ana Cristina
Rev. Bras. Psiquiatr., In press 2007
TEXTO
GRATUITO
3 - Detecção
precoce: é possível prevenir a esquizofrenia?
LOUZA, Mário
Rodrigues
Rev. psiquiatr. clín., 2007, vol.34 suppl.2, p.169-173
TEXTO
GRATUITO
3 -
Alterações cognitivas na esquizofrenia: conseqüências funcionais e abordagens
terapêuticas
MONTEIRO, Luciana de
Carvalho and LOUZA, Mário Rodrigues
Rev. psiquiatr. clín., 2007, vol.34 suppl.2, p.179-183
TEXTO GRATUITO
3 - Ganho de peso e alterações metabólicas
em esquizofrenia
LEITAO-AZEVEDO,
Carmem Lucia, GUIMARAES, Lísia Rejane, LOBATO, Maria Inês et al
Rev. psiquiatr. clín., 2007, vol.34 suppl.2, p.184-188
TEXTO GRATUITO
3 - Novos antipsicóticos para o tratamento
da esquizofrenia
ELKIS, Hélio and
LOUZA, Mário Rodrigues
Rev. psiquiatr. clín., 2007, vol.34 suppl.2, p.193-197
TEXTO GRATUITO
3 - Fisiopatologia da esquizofrenia:
aspectos atuais
ARARIPE NETO, Ary
Gadelha de Alencar, BRESSAN, Rodrigo Affonseca and BUSATTO FILHO, Geraldo
Rev. psiquiatr. clín., 2007, vol.34 suppl.2, p.198-203
TEXTO GRATUITO
3! - The Effect of Food on the
Absorption of Oral Ziprasidone
Jeffrey J. Miceli,
Paul Glue, Jeffrey Alderman, and Keith Wilner
Psychopharmacology Bulletin. 2007;40(3):58-68
3 - Do Antipsychotic Drugs
Influence Suicidal Behavior in Schizophrenia?
Eduardo J. Aguilar, and
Samuel G. Siris
Psychopharmacology Bulletin. 2007;40(3):128-142
3 - How Long
do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?
Johannes Hamann,
Werner Kissling, and Stefan Leucht